Cortechs.ai Gets FDA Clearance for NeuroQuant PET

Aug 18, 2026
Cortechs.ai said NeuroQuant PET received FDA 510(k) clearance for PET. The software provides automated PET quantification and structured reporting for cognitive impairment and other neurological conditions.
Cortechs.ai Gets FDA Clearance for NeuroQuant PET

Cortechs.ai announced in a press release that NeuroQuant PET received U.S. Food and Drug Administration (FDA) 510(k) clearance for PET. The software aids physicians in evaluating patient pathologies and interpreting PET studies for cognitive impairment and other neurological conditions.

NeuroQuant PET provides automated quantification, regional analysis, and structured reporting for clinical workflows. It supports amyloid PET tracers including flutemetamol, florbetaben, and florbetapir, and generates standardized uptake value ratios and Centiloid measurements.

The platform supports PET CT, PET MR, and PET only workflows. It segments regions of interest and creates outputs prepared for PACS integration.

We hope you enjoyed this article

Consider subscribing to one of our newsletters like Life AI Weekly or Daily AI Brief.

Also, consider following us on social media:

Free newsletter

Life AI Weekly

Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.

Industry analysis

2025 Global Business Services Agenda: Gen AI Takes Center Stage

The Hackett Group

This industry analysis by The Hackett Group explores the transformative impact of generative artificial intelligence (Gen AI) on global business services (GBS) in 2025. The study highlights the shift from exploration to acceleration of Gen AI initiatives, with 89% of executives advancing these projects to improve customer satisfaction, innovate products, and reduce costs. The report also discusses the challenges and strategies for successful Gen AI adoption, emphasizing the need for a technology-enabled operating model and the importance of reskilling the workforce.

Read more
Free, six days a week

Daily AI Brief: the AI news that matters, in your inbox.